The accuracy of digital symptom checkers for both triage and diagnosis is generally low, which could pose a risk to patient safety, according to a review of studies published in npj Digital Medicine.
Researchers compiled 10 studies that evaluated a total of 48 online symptom checkers. Half of the studies used real patients, while the other half studied simulated cases. The review found primacy...
Indian connected health device maker Dozee has partnered with Midmark India, one of the biggest hospital bed manufacturers in South Asia, to launch a connected bed platform for non-ICU settings.
WHAT IT DOES
According to a press statement, their smart bed will enable hospitals to continuously monitor patients' conditions in step-down ICUs and other non-ICU wards. The connected bed is integrated...
Mental health continues to be a leading clinical focus for digital health investors. There's plenty of competition in the space, but it's still a big challenge for the healthcare system: Many Americans live in areas with a shortage of mental health professionals, limiting access to care.
Wysa, maker of an AI-backed chatbot that aims to help users work though concerns like anxiety, stress and low...
In the midst of controversy surrounding the digital mental health company's prescribing practices and a week after it replaced its CEO, Cerebral revealed a transformation plan focused on growth and patient experience.
The program, called Cerebral Core, includes objectives to review quality practices as well as improve the user and clinician experience.
The company said it plans to add in-network...
Cerebral will stop prescribing most controlled substances to new and existing patients, the embattled digital mental health company confirmed to Insider.
According to an email sent to staff on Monday, Cerebral CEO Kyle Robertson said the company would halt prescriptions of controlled substances like Adderall and Xanax for new patients starting May 20 and for existing patients starting October 15...
Amid growing controversy over Cerebral's prescribing practices, the digital mental health company will pause prescriptions of controlled substances like Adderall and Ritalin for new patients.
The suspension will begin Monday, May 9, though existing patients can continue to receive their prescribed medications.
"It is regrettable that a helpful class of medication that is considered a first-line...
A former Cerebral employee is suing the digital mental health company, alleging he was fired after voicing concerns about unethical prescribing practices and patient safety issues.
In the suit, filed earlier this week in a California state court and first reported by Bloomberg Law, former Cerebral vice president for product and engineering, Matthew Truebe, said he was let go a year after he was...
Healthnet Global, a subsidiary of hospital chain Apollo Hospitals, has unveiled its smart in-patient room automation system that features remote patient monitoring and triaging.
WHAT IT DOES
Its latest hospital automation offering, AutoMaid, comes with motion sensors, including bed handrail sensors that patients can use to notify nurses. It has a communication pod that enables touch and voice...
Dutch health tech giant Royal Philips has scored FDA 510(k) clearance for its IntelliVue MX750 and MX850 patient monitors.
The monitors, which received an FDA emergency use authorization in 2020 and were cleared in Europe with a CE mark in 2019, are designed to support clinical decisions, manage a patient’s condition and needs, and improve infection control within a hospital setting.
WHY IT...
Sound Life Sciences scored FDA 510(k) clearance for its prescription app that uses a smartphone or smart speaker to monitor respiration at home or in a clinical setting.
The tool works by allowing a smartphone or speaker to emit inaudible ultrasonic pulses that bounce off a patient’s chest and are reflected back to the device. The app uses signal processing algorithms to note any significant...
_3.jpg?itok=Z9j4dMvu "An older man wearing headphones and holding a smartphone")
